Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1100 of 1631 entries
View as:

A Study to Learn About Venous Thromboembolism (VTE) Treatment With Rivaroxaban in Japanese Patients Using a Claims Database

Phase: N/A Priority: Normal
NCT ID: NCT04923139 Org: User:
Start: 01/24/22 End: 12/31/22 Due: 12/31/23

Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack

Phase: N/A Priority: Normal
NCT ID: NCT04304534 Org: User:
Start: 06/17/20 End: 02/21/22 Due: 02/21/23

An Observational Study Called ROVER to Learn More About How Well Vericiguat Works in People Who Were Newly Treated With Vericiguat in Routine Medical Care in Germany

Phase: N/A Priority: Normal
NCT ID: NCT06486844 Org: User:
Start: 07/05/24 End: 07/31/25 Due: 07/31/26

Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental Pain

Phase: N/A Priority: Normal
NCT ID: NCT01280591 Org: User:
Start: 10/31/10 End: 02/28/11 Due: 02/28/12

Effect of Piroxicam on Ovulation

Phase: N/A Priority: Normal
NCT ID: NCT01320709 Org: User:
Start: 03/31/11 End: 05/31/12 Due: 05/31/13

Safety Study of BAY73-4506 in Patients With Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01003015 Org: User:
Start: 09/30/09 End: 03/31/13 Due: 03/31/14

A Study Using Surveys to Learn More About Treatment With Steroidal Mineralocorticoid Receptor Antagonists, How They Are Used, What Side Effects They Have, and How Satisfied People Who Receive Them Are in the US

Phase: N/A Priority: Normal
NCT ID: NCT05407662 Org: User:
Start: 11/02/22 End: 06/13/23 Due: 06/13/24

Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT02971930 Org: User:
Start: 06/20/17 End: 12/15/17 Due: 12/15/18

Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema)

Phase: N/A Priority: Normal
NCT ID: NCT01512966 Org: User:
Start: 01/31/12 End: 09/30/13 Due: 09/30/14

Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection

Phase: N/A Priority: Normal
NCT ID: NCT01069900 Org: User:
Start: 07/21/10 End: 01/21/15 Due: 01/21/16

Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED

Phase: N/A Priority: Normal
NCT ID: NCT00492635 Org: User:
Start: 12/31/04 End: 09/30/07 Due: 09/30/08

Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01788358 Org: User:
Start: 02/14/13 End: 05/01/14 Due: 05/01/15

Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone

Phase: N/A Priority: Normal
NCT ID: NCT01955694 Org: User:
Start: 11/11/13 End: 02/20/15 Due: 02/20/16

Repinotan in Patients With Acute Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00044915 Org: User:
Start: 12/31/00 End: 09/30/04 Due: 09/30/05

BAY81-8973 Pediatric Safety and Efficacy Trial

Phase: N/A Priority: Normal
NCT ID: NCT01311648 Org: User:
Start: 06/09/11 End: 10/27/20 Due: 10/27/21

Study of the Influence of Liver Function on Blood Concentrations of Runcaciguat in Participants With Different Degrees of Liver Impairment

Phase: N/A Priority: Normal
NCT ID: NCT04820621 Org: User:
Start: 04/07/21 End: 07/01/21 Due: 07/01/22

An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT02303444 Org: User:
Start: 04/08/15 End: 07/24/20 Due: 07/24/21

Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens

Phase: N/A Priority: Normal
NCT ID: NCT00927667 Org: User:
Start: 06/30/09 End: 12/31/10 Due: 12/31/11

Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD)

Phase: N/A Priority: Normal
NCT ID: NCT01228513 Org: User:
Start: 11/30/10 End: 04/30/12 Due: 04/30/13

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT01606995 Org: User:
Start: 06/12/12 End: 03/31/15 Due: 03/31/16

Stivarga Regulatory Post-Marketing Surveillance Study in Korea

Phase: N/A Priority: Normal
NCT ID: NCT02106858 Org: User:
Start: 06/25/14 End: 05/07/19 Due: 05/07/20

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

Phase: N/A Priority: Normal
NCT ID: NCT02504216 Org: User:
Start: 08/18/15 End: 01/09/20 Due: 01/09/21

VICTOR - Avelox® Intravenous (i.v.) in Acute Exacerbations of Chronic Bronchitis

Phase: N/A Priority: Normal
NCT ID: NCT00876577 Org: User:
Start: 05/31/09 End: 03/31/11 Due: 03/31/12

Phase I Study of Sorafenib Dosed Continuously With Cyclophosphamide and Doxorubicin

Phase: N/A Priority: Normal
NCT ID: NCT00562913 Org: User:
Start: 12/31/07 End: 03/31/10 Due: 03/31/11

BAY14-2222 Continuous Infusion in Surgeries

Phase: N/A Priority: Normal
NCT ID: NCT00606060 Org: User:
Start: 07/31/04 End: 05/31/05 Due: 05/31/06